Menu
Not yet recruiting NCT07375810

Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard

Observational Coronary Artery Disease (CAD)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: AI-ECG Analysis.
Who it may be relevant to
Registry conditions: Coronary Artery Disease (CAD). Basic parameters: 18 years — 89 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Study to Measure Underlying Coronary Stenosis; a Retrospective, Multi-center Study to Measure Efficacy of ECGio Against Multiple Reference Standards

Overview

The study objective is to evaluate the effectiveness of the ECGio algorithm in predicting clinically significant coronary artery disease . ECGio's diagnostic performance during the trial will be compared against an objective performance ¬criteria using a mixed reference standard of quantitative coronary angiography and quantitative coronary computed tomography angiography in patients a general adult population under suspicion of coronary artery disease.

Interventions

  • Device AI-ECG Analysis
    The AI-Analysis done on the ECGs in a retrospective fashion

Primary outcome measures

  • Sensitivity & Specificity [Time frame: Within 30 days of enrollment]
Secondary outcome measures (3)
  • Sensitivity & Specificity [Time frame: For the first 300 patients referred to invasive angiography through study completion, an average of 90 days]
  • Demographic Performance [Time frame: For patients in the 30 days following computed tomography angiography]
  • Angiographic Stenosis Prediction [Time frame: For the first 300 patients referred to invasive angiography through study completion, an average of 90 days]

Eligibility criteria

Inclusion criteria

  • Patients 18 years of age or older at time of data collection.
  • Patients with medical records stored in a digitized format.
  • Patients under suspicion of coronary artery disease (both suspicion of significant coronary artery disease as well as to rule out significant CAD) who present to the site with an electrocardiogram recorded up to 30 days prior to Coronary Computed Tomography Angiography.

Exclusion criteria

  • Patients with acute coronary syndrome.
  • Patients who previously underwent coronary artery bypass grafting.
  • Patients whose electrocardiogram tracing has extreme noise or artifact to the extent that it would be recommended to redo the tracing.
  • Patients with prior percutaneous coronary intervention resulting in stenting.
  • Unanalyzable invasive coronary angiogram.
  • Unanalyzable Coronary Computed Tomography Angiography.
  • Unanalyzable electrocardiogram signal.
  • Incomplete invasive coronary angiogram (e.g., only the right coronary artery was injected and visualized).
  • Patient core lab analyzed Coronary Computed Tomography Angiography showed ≥ 50% blockage in any vessel but patient was not referred to invasive coronary angiogram.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 2 centers
  • Medstar Washington Hospital Center — Washington D.C.
  • Cena Research Institute — Houston

Publications

  • Leasure M, Jain U, Butchy A, Otten J, Covalesky VA, McCormick D, Mintz GS. Deep Learning Algorithm Predicts Angiographic Coronary Artery Disease in Stable Patients Using Only a Standard 12-Lead Electrocardiogram. Can J Cardiol. 2021 Nov;37(11):1715-1724. doi: 10.1016/j.cjca.2021.08.005. Epub 2021 Aug 20. PMID 34419615

Identifiers

NCT: NCT07375810 · HIO0004A

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗